Please assess the completion status of the following clinical trial:

Trial Title: Intra-Operative Dural Brachytherapy With Yttrium-90 Plaque Applicators

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Pathological diagnosis of malignant tumor involving spine with extraosseous extension or arising in paraspinal soft tissues with tumor involving or abutting the dura. Patients with a limited metastatic disease and tumor involving the spine or paraspinal soft tissues and who are judged to benefit from surgery will also be eligible.~* Lesion may be primary or recurrent after prior surgery~* No clinical, radiographic or other evidence of distant metastatic tumor~* Fit for receiving the planned radiation dose to the affected site. No known genetic disease or medical condition associated with an abnormal radiation sensitivity.~* 18 years of age or older~* KPS of 70 or greater (excluding consideration of poor function due to the local growth or systemic metabolic effects of the tumor~Exclusion Criteria:~* Disease/conditions characterized by high radiation sensitivity~* Pregnancy~* Evidence of cord/cauda malfunction for causes other than effect os local tumor growth or due to metabolic effects of tumor

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Dural brachytherapy plaque (Type: EXPERIMENTAL): Patients undergoing spine tumor resection will undergo dural plaque brachytherapy.

Based on this trial design, predict the completion outcome and termination type (if applicable).